Keros Therapeutics, Inc. - KROS
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 27, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | ExodusPoint Capital Management, LP | 0.04% | 13,360 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | ExodusPoint Capital Partners GP, LLC | 0.04% | 13,360 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Michael Gelband | 0.04% | 13,360 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Madison Avenue International LP | 2.7% | 823,707 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Madison Avenue Partners, LP | 2.7% | 823,707 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | EMAI Management, LLC | 2.7% | 823,707 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Madison Avenue GP, LLC | 2.7% | 823,707 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Caraway Jackson Investments LLC | 2.7% | 823,707 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Eli Samaha | 2.7% | 823,707 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | TANG CAPITAL MANAGEMENT, LLC | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | KEVIN TANG | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | TANG CAPITAL PARTNERS, LP | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | TANG CAPITAL PARTNERS INTERNATIONAL, LP | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | TANG CAPITAL PARTNERS III, INC | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | TANG CAPITAL PARTNERS IV, INC | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | D. E. Shaw & Co., L.P. | 3.9% | 756,156 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | D. E. Shaw & Co., L.L.C. | 3.9% | 755,473 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | David E. Shaw | 3.9% | 756,156 | View |
| Jan 30, 2026 | SCHEDULE 13G/A | The Vanguard Group | 5.0% | 1,525,355 | View |
| Nov 18, 2025 | SCHEDULE 13G | ExodusPoint Capital Management, LP | 6.3% | 1,907,899 | View |
| Nov 18, 2025 | SCHEDULE 13G | ExodusPoint Capital Partners GP, LLC | 6.3% | 1,907,899 | View |
| Nov 18, 2025 | SCHEDULE 13G | Michael Gelband | 6.3% | 1,907,899 | View |
| Oct 27, 2025 | SCHEDULE 13G | D. E. Shaw & Co., L.P. | 5.1% | 1,545,948 | View |
| Oct 27, 2025 | SCHEDULE 13G | D. E. Shaw & Co., L.L.C. | 5.0% | 1,537,348 | View |
| Oct 27, 2025 | SCHEDULE 13G | David E. Shaw | 5.1% | 1,545,948 | View |
| Oct 22, 2025 | SCHEDULE 13G | TANG CAPITAL MANAGEMENT, LLC | 7.9% | 2,418,984 | View |
| Oct 22, 2025 | SCHEDULE 13G | KEVIN TANG | 7.9% | 2,418,984 | View |
| Oct 22, 2025 | SCHEDULE 13G | TANG CAPITAL PARTNERS, LP | 5.2% | 1,579,237 | View |
| Oct 22, 2025 | SCHEDULE 13G | TANG CAPITAL PARTNERS INTERNATIONAL, LP | 2.7% | 839,747 | View |
| Oct 22, 2025 | SCHEDULE 13G | TANG CAPITAL PARTNERS III, INC | 0.0% | 0 | View |
| Oct 22, 2025 | SCHEDULE 13G | TANG CAPITAL PARTNERS IV, INC | 0.0% | 0 | View |
| Oct 16, 2025 | SCHEDULE 13D/A | — | 5.0% | — | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.